Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
FRIDAY, Dec. 9, 2022 (HealthDay News) — Patients with COVID-19 taking molnupiravir or nirmatrelvir-ritonavir rarely have viral rebound, and rebound is not associated with increased mortality risk, according to a study published online Dec. 6 in JAMA …
Learn MoreRecommendations Updated for Treatment, Prevention of HIV
FRIDAY, Dec. 9, 2022 (HealthDay News) — In a special communication article published online Dec. 1 in the Journal of the American Medical Association, the International Antiviral Society-USA Panel presents updated recommendations for the use of antir…
Learn MoreFully Online College Classes Tied to Greater Psychological Distress
FRIDAY, Dec. 9, 2022 (HealthDay News) — Fully remote college classes were associated with higher levels of psychological distress during 2021 for students compared with those attending hybrid format classes, according to a study published online Nov….
Learn More1.3 Million Older Women Still Receive Cervical Cancer Screening-Related Services
FRIDAY, Dec. 9, 2022 (HealthDay News) — While annual use of cervical cancer screening-associated services is decreasing in the Medicare fee-for-service population, more than 1.3 million older women received these services in 2019, according to a stud…
Learn MoreHalf of U.S. Adults Not Concerned About the Flu
FRIDAY, Dec. 9, 2022 (HealthDay News) — More than half of U.S. adults say they are not very or not at all concerned about the upcoming flu season, according to the results of a survey released Nov. 29 by the American Heart Association.The online surv…
Learn MoreOne in Seven U.S. Adults Report Past-Week Bloating
FRIDAY, Dec. 9, 2022 (HealthDay News) — Nearly one in seven U.S. adults report experiencing bloating in the past week, according to a study published online Nov. 14 in Clinical Gastroenterology and Hepatology.Janice E. Oh, M.D., from Cedars-Sinai Med…
Learn MorePaxlovid Safe for Pregnant Patients With COVID-19
FRIDAY, Dec. 9, 2022 (HealthDay News) — Pregnant patients treated with nirmatrelvir and ritonavir (Paxlovid) for COVID-19 tolerate the treatment well, according to a study published online Nov. 29 in JAMA Network Open.William M. Garneau, M.D., from t…
Learn MoreBlack Patients Have Worse Percutaneous Coronary Intervention Outcomes
FRIDAY, Dec. 9, 2022 (HealthDay News) — Black patients have a higher risk for 90-day readmission and mortality following percutaneous coronary intervention (PCI) than White patients, according to a study published online Nov. 11 in the American Heart…
Learn MoreWorkplace Fumes, Dust Could Raise Odds for Rheumatoid Arthritis
FRIDAY, Dec. 9, 2022 (HealthDay News) — The air where you work could be increasing your risk of developing rheumatoid arthritis, a new study suggests.Breathing in the fumes from commercial vapors, gases and solvents — and even common dusts found in …
Learn MoreGene Test Might Help Some Breast Cancer Patients Skip Radiation After Lumpectomy
FRIDAY, Dec. 9, 2022 (HealthDay News) — A new genetic test may help determine which people with breast cancer can safely skip radiation after breast-conserving surgery to remove their tumor.Individuals with invasive breast cancer who had low scores o…
Learn More